Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

MorphoSys and Heptares enter GPCR antibody agreement

Feb. 13, 2013

RQx Pharmaceuticals and Genentech form drug discovery collaboration

Feb. 13, 2013

Lycera enters into new collaboration with Merck & Co.

Feb. 13, 2013

Champions Oncology receives on-time payment under Teva technology collaboration

Feb. 12, 2013

Albany Molecular Research out-licenses tubulin inhibitor

Feb. 12, 2013

Bayer HealthCare to coordinate newly founded pan-European consortium

Feb. 11, 2013

Venaxis signs agreement with EMELCA Bioscience for E.U. launch of novel appendicitis test APPY1

Feb. 8, 2013

Dyax and CVie Therapeutics sign agreement for Kalbitor

Feb. 8, 2013

Pergamum and Cadila Pharmaceuticals enter strategic collaboration

Feb. 8, 2013

Biogen acquires full rights to Tysabri

Feb. 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...